BGPT: Paper Review: Complement activation by phospholipids: the interplay of factor H and C1q

Explore by Goal

Quick Explanation Copied

Core finding: anionic phospholipids (e.g., cardiolipin) recruit both C1q (classical pathway initiator) and factor H (typically known for alternative-pathway control); their competitive binding to the same lipid target directly shifts the classical pathway output, with factor H downregulating C4 deposition in reconstituted sera.

Long Explanation

Paper review (science-first): C1q vs factor H on phospholipids

Target question: How do anionic phospholipids trigger complement, and can factor H—classically framed as an alternative-pathway regulator—directly regulate classical pathway activation at the lipid surface?

1) Mechanistic map (from the paper’s experimental logic)

Step A: Both C1q and factor H bind anionic phospholipids (tested: PA, CL, PS, PG, PI; plus neutral controls PE, PC), with overlapping binding specificity and direct competition.

Step B: In serum, anionic phospholipids consume complement primarily via the classical pathway, with negligible alternative-pathway consumption.

Step C: Because factor H competes for lipid binding, it downregulates classical pathway activation directly: increasing factor H:C1q ratios reduce C4b deposition in CL-coated wells using C1q- and factor H-depleted/repleted human sera.

2) Visual: phospholipid panel—classical consumption vs alternative consumption

Based strictly on the paper’s qualitative assay outcomes (classical consumption observed for anionic lipids; alternative consumption reported as absent/none for the tested panel in the alternative-pathway assay).

3) Key experiments and what they actually prove

3.1 Binding assays (C1q, factor H, β2-glycoprotein-1)

Direct binding specificity: C1q binds most strongly to anionic phospholipids in well-based assays and shows a distinct profile on liposomes (notably, PE binding differs between plate-bound vs bilayer contexts, which the authors discuss as potentially artifactual).
Factor H binding breadth: factor H binds all anionic phospholipids tested (with weaker binding to PS), and is negligible on neutral lipids PE/PC in their binding assays.
Competition is demonstrated: factor H competes with C1q for CL binding, and β2-glycoprotein-1 (β2GPI; also called β2-1/apolipoprotein H in older naming) potently inhibits C1q binding to CL-coated wells.

3.2 Functional readouts: classical complement activation & alternative-pathway silence

Using an IgG-depleted serum complement consumption assay, the paper reports that multiple anionic phospholipids consume complement consistent with classical pathway activation (while neutral PC fails; PE shows consumption at plate-level but not in liposomes in their data narrative).
In contrast, the same phospholipid panel produced no detectable alternative-pathway consumption in their alternative-pathway hemolytic assay.

3.3 The “interplay” claim hinges on a C4b deposition test

Because factor H regulates alternative-pathway C3 turnover, they use C4b deposition (upstream of C3) as a classical-pathway activation marker, in C1q- and factor H-depleted serum repleted with fixed C1q and variable factor H.
The paper reports that increasing factor H:C1q reduces C4b deposition monotonically, supporting direct downregulation of classical pathway activation by factor H via lipid competition.

3.4 C1q binding site: globular head (A/B/C) mediates phospholipid interaction

The paper tests recombinant globular head domains (ghA, ghB, ghC) and shows each binds phospholipids similarly to native C1q, supporting the model that C1q’s globular head is responsible for anionic phospholipid interaction (with nuance for PE plate-bound vs bilayer conditions).
They show C1q competes out ghA/ghB/ghC binding to CL, consistent with overlapping or similar binding modes.

4) Skeptical critique: strengths, blind spots, and what could be misleading

Strengths

Cross-validating binding with function: binding competition (C1q vs factor H, and β2GPI effects) is connected to complement activation outputs (classical consumption; C4b deposition downregulation with factor H:C1q ratio).
Mechanistic control for pathway confounding: choosing C4b deposition as a readout to avoid factor H’s known influence on C3 turnover strengthens causal interpretation regarding the classical pathway initiation step.

Blind spots & uncertainties (what the data do NOT fully settle)

Physiological relevance of lipid presentation: the study uses solid-phase lipid coatings and multilamellar liposomes with defined compositions; these may not replicate in vivo phospholipid density, geometry, leaflet asymmetry, oxidation state, or membrane-protein context. The paper itself notes contextual dependence, especially with PE plate-bound vs bilayer behavior.
Competition is demonstrated but “complete overlap” is not proven: factor H inhibits C1q binding substantially but the paper reports ~partial inhibition at certain molar ratios and interprets competition as overlapping sites on CL. Partial inhibition can reflect multiple binding surfaces, avidity effects, or differences in stoichiometry/geometry between proteins and lipid patches.
Immunoglobulin effects appear “later-stage” but are not fully mechanistically decomposed: IgM/IgG presaturation increases classical complement consumption even though measured effects on C1q binding are small, implying effects on C4 fixation or downstream assembly. However, the paper does not exhaustively partition all downstream steps.

5) What would most disprove the paper’s central “interplay” model?

If factor H did not reduce C4b deposition (classical initiation) when its molar ratio to C1q is increased in C1q/factor-H depleted/repleted serum under the same lipid target conditions, the direct classical-pathway regulation claim would be undermined.
If factor H and C1q did not meaningfully compete for CL binding under the same experimental conditions, then the lipid-level competition mechanism would be weakened.
If recombinant C1q globular heads (ghA/ghB/ghC) could not bind anionic phospholipids in the same qualitative pattern as native C1q, then the proposed “globular head mediates binding” interpretation would be less credible.

Author-review deep dives (open-ended)

Click for bespoke BGPT “Author Review” prompts for each full author listed in the paper.

Feedback:

Updated: April 16, 2026